March 23, 2020

March 23, 2020

Holidays

Pakistan Day
Celebrated in: Pakistan

Legal Holidays by Countries

Pakistan DayPakistan
References in periodicals archive ?
Instead of being an eight-hour work day, from March 23, 2020 onwards, it should be a nine-hour work day every year and the extra working hour on that day should be dedicated to the nation.
The award will be presented in a grand ceremony at President House, Islamabad, on March 23, 2020.
The president will confer these awards at a ceremony to be held on the next Pakistan Day March 23, 2020. A graduate of the National College of Arts (NCA), Beyg has been an integral part of the Pakistan fashion industry.
The Scottish singer has announced a date at the Liverpool Empire on March 23, 2020, as part of the TEN Tour.
On March 23, 2020, the FDA will be able to license such interchangeable products.
Investigations on the Roman treasures of Annecy" (provisional title) to be presented at the Muse-Chteau d%Annecy, Place du Chteau, 74000 Annecy, from November 28, 2019 to March 23, 2020.
However, since March 21 is a Saturday (i.e., not a business day), the conversion of the biological product NDAs will occur at 12:00 am on Monday, March 23, 2020. Also, at this date and time, the NDAs for these products will no longer exist in the FDA's data system and the associated products and their applications will commence being regulated under the PHSA as biological products and BLAs, respectively.
As noted above, any 3-year or 5-year exclusivity applied to an NDA-approved biological product will end at midnight on March 20, 2020, and will not confer to the product when its NDA becomes a BLA at 12 AM on Monday morning March 23, 2020. Likewise, biological product NDAs that are "deemed to be a license" will not be granted the 12-year and 4-year exclusivity periods provided under 351 (k) (7) (A) of the PHSA to BLAs that are first approved under 351(a) of that Act.
She succeeds Arsalia Byrd and is appointed for a term beginning December 1, 2017, and ending March 23, 2020.
The BPCIA provides that FDCA Biological Products shall be deemed to have biologics license applications (BLAs) on March 23, 2020.3 In addition, the BPCIA provides that prior to March 23, 2020, a proposed follow-on of a FDCA Biological Product may be submitted under the FDCA if there is no other biological product licensed under a BLA that could be a reference product.4 According to the Draft Guidance, FDCA Biological Products will no longer exist as NDAs or ANDAs and will be replaced by approved BLAs under section 351(a) or 351(k) of the PHSA on March 23, 2020.5
Sponsors of recently approved FDCA Biological Products stand to lose valuable exclusivities on March 23, 2020, with nothing to show in return.